Products and Resources Catalog

Co-occurring disorders (CODs) occur frequently and can significantly impact mother and child. In this webinette, Dr. Cooke will present information on the significance of CODs and their risk factors; discuss the importance of repeat screening, appropriate referral, and coordinated treatment; and share the safety profiles of the various medications available to treatment CODs and how to take in account the risks to mother and child.

This is a training on Technology-Assisted Care and will improve awareness of and receptivity to using Technology-Assisted Care (TAC) for the treatment of Substance Use Disorders (SUDs).

This white paper is intended to provide a series of recommendations to guide practitioners in achieving more integrated behavioral health services in their respective settings. The paper presents Screening, Brief Intervention, Referral to Treatment (SBIRT) as a guiding clinical framework and identifies organizational change activities that are necessary to fully implement integrated treatment models.

The effects of prenatal alcohol exposure represent a leading preventable cause of developmental delays in the United States. Fetal alcohol spectrum disorders (FASD) represent the range of lifelong effects that can occur, including cognitive, behavioral, and/or social deficits. This lunch break will provide an overview of FASD and provide resources to adapt women’s treatment programs to increase success for women with an FASD.

These monographs provide insight and analysis of the topics important to today’s addiction counselors and recovery coaches: recovery-oriented systems of care, recovery management, peer-based recovery services, and treating addiction as a chronic condition that requires ongoing management.

The addictions treatment field is reaching a tipping point that is revolutionizing the ways that behavioral health leaders think about people with alcohol and other drug problems—and how services and systems are developed. Recovery Management / Recovery Oriented Systems of Care contains six monographs by renowned recovery advocate William L. While and colleagues.

Dr. Thomas E. Freese, Director of the Pacific Southwest ATTC, explains what is meant by "medical" marijuana, who uses it and why, and the difference between medical marijuana and FDA approved medications.

Q&A with marijuana expert Dr. Kevin Hill. Topics include Addiction/dependency, adolescence, effects on the body, medical marijuana, potency, and withdrawal.

ATTC Network Efforts and Activities in Integrating Substance Use Disorder and Health Care Services

The main goals of this white paper are to emphasize the need for better integration of substance use disorder (SUD) and health care services and describe an array of effective models, interventions and implementation strategies for treating SUDs in health care settings, highlighting efforts of the ATTC Network.

Dr. Wilson M. Compton, Deputy Director at NIDA, highlights the adverse effects of marijuana use can have on the brain, heart, and respiratory. The video also provides some information on second hand exposure and current marijuana potency.

This Issue Brief describes the ATTC Network’s plans to advance the integration of care.

The goal of this training course is teach participants how to develop their skills to deliver Screening, Brief Intervention, and Referral to Treatment (SBIRT). The assumption in designing this course is that participants have already completed the self-paced online course (Foundations of SBIRT) that introduced the topic of SBIRT. The aim of this training course is to help participants to (1) develop skills related to SBIRT, and to (2) begin a conversation around implementation of SBIRT.

This revision of the March 2012 face-to-face version of the Pacific Southwest ATTC’s SBIRT curriculum was prepared by the National Screening, Brief Intervention and Referral to Treatment ATTC. The goals of the training remain the same: to help participants to develop skills related to SBIRT, and to begin a conversation around implementation of SBIRT in standard practice. The revised curriculum expands the format and presents the trainer with the opportunity to focus on any 1 of 4 option.

The purpose of this introductory training is to provide HIV clinicians (including, but not limited to physicians, dentists, nurses, and other allied medical staff, therapists and social workers, and counselors, specialists, and case managers) with a detailed overview of screening patients for at-risk alcohol and other drug use and conducting a brief intervention with patients to reduce their at-risk substance use.

El propósito del Paquete de Entrenamiento de Integración de VIH es para proveer a especialistas del VIH (incluyendo, pero no limitado a doctores, dentistas, enfermeras, y otros empleados médicos, terapistas, trabajadores sociales, y consejeros, especialistas, y manejadores de casos) con una visión general de tratamiento integral para las personas que viven con el VIH.

The purpose of the HIV Integration Training Package is to provide HIV clinicians (including, but not limited to physicians, dentists, nurses, and other allied medical staff, therapists and social workers, and counselors, specialists, and case mangers) with an overview of integrated treatment for individuals living with HIV. The main focus of the training is the integration of mental health and substance use disorder treatment services with HIV care.

These practice guidelines are framed by the notions of recovery and resilience. It is this framework, and an unwavering belief in recovery and resilience in behavioral health, that should be the basis for service delivery.

Self-paced online course that contains six modules of instruction covering topics related to Screening, Brief Intervention, and Referral to Treatment (SBIRT) Model. Topics include: understanding the scope of alcohol and drug abuse/dependence; research why dentists need to understand SUDs; and an overview on how to implement the SBIRT model in dental settings.

In recognition of Recovery Month 2011, this year's essay contest invited individuals who have been supported in their recovery by medications, including methadone or buprenorphine for opioid addiction and acamprosate or naltrexone for alcohol addiction, to share their stories.

The Journal of the Arizona Dental Association-Inscriptions, Volume 25, Number 13, September 2011 featured an article focused on the potential of patient abuse of prescription drugs, especially opioid based medication prescribed by dental practitioners to manage pain. Provided in the article are data and ways to engage patients in conversation regarding their prescription drug use.

This book comprises 20 essays in which family members described, in their own words, the most challenging part about having a family member with a substance use disorder, what it means to have a loved one find long-term recovery and explain why they are committed to recovery.

Opioid abuse and addiction (e.g., heroin, OxyContin) remains a critical national public health concern. In 2002, tablet formulations of the medication Buprenorphine were approved by the Food and Drug Administration for the treatment of opioid addiction. In order to prepare the field to effectively integrated this new treatment, the Buprenorphine Treatment Blending Team developed an awareness training to disseminate information and enhance awareness among multidisciplinary (non-physician) addiction professionals about Buprenorphine treatment. This training is designed to provide a broad overview of the medication, its effects, and the role of non-physician practitioners in providing and supporting the treatment of individuals receiving this medication.